According to the latest research by Persistence Market Research, the nephro genetic testing market is set to witness positive growth of CAGR 5.5% during 2021-2031. Nephrogenetic disorder are hereditary and are passed from one generation to another.
These are caused by any genetic alteration in the genes affecting the kidney functions and formation of renal cyst. Some of the common genetic renal disorders include Autosomal Dominant Polycystic Kidney Disease (ADPKD), Gitelman Syndrome, Nephronophthisis, etc.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32872
The nephro genetic testing market is majorly driven by advancements in DNA sequencing techniques and increasing research in the domain. These method provide an accurate course of treatment and specific investigations.
The market is majorly driven by increase in the prevalence of genetic renal disorders, technological advancements in the screening techniques, awareness about genetic testing and increasing research and development. Various technological advancements are happening in DNA sequencing. Next-generation sequencing is the new method that is currently used for DNA sequencing.
Another driver is the prevalence of various nephrological disorders. According to report, the genetic renal disorder affects 5-15% of adult population. This increase in the prevalence therefore acts as a driven for nephrological testing market.
An increase in the awareness about the genetic testing for the disorder and R & D investment by the companies for developing new techniques is expected to increase demand for nephrogenetic testing during the forecast period.
COVID-19 had an impact on the nephrogenetic testing market. Since only the essential treatments were allowed during the pandemic, the screening and many early signs of nephrogentic disorders went undetected.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32872
During this pandemic times, the hospitals started giving nephrogenetic counselling through telephone videoconferencing (telegenetics) for remote places. However, this pandemic has allowed researchers to come up with new techniques for nephrogenetic testing. The market had an overall negative impact due to COVID-19.
Some of the leading manufacturers of nephrogenetic testing include,
- Centogene N.V.
- MedGenome
- Blueprint Genetics Oy
- Invitae Corporation
- Natera Inc.
North America with countries like US and Canada re dominating the nephrogenetic market. The presence of major players and increase in the investments by them are driving the market.
Also, the governmental initiatives for genetic testing and increase in funding act as a driver for the market. In addition to this, the prevalence rate of genetic renal disorder is high. For instance, according to a report, 13% of blacks in US carry APOL1 gene, which is responsible for causing renal diseases.
Another region that is expected to dominate the market is Asia followed by Europe. This is due to presence of some player like MedGenome in this region and increase in life science research is expected to drive the market.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32872
Key Segments:
By Technique
- Next generation sequencing
- Multiplex Ligation-dependent Probe Amplification (MLPA)
By End-user
- Hospitals
- Specialty clinics
- Research institutes
- Diagnostics laboratories
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
